[HTML][HTML] Biologics for targeting inflammatory cytokines, clinical uses, and limitations
P Rider, Y Carmi, I Cohen - International journal of cell biology, 2016 - hindawi.com
Proinflammatory cytokines are potent mediators of numerous biological processes and are
tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and …
tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and …
Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases
Y Lai, C Dong - International immunology, 2016 - academic.oup.com
Inflammatory cytokines are key regulators of immune responses. Persistent and excessive
production of inflammatory cytokines underscores the development of autoimmune …
production of inflammatory cytokines underscores the development of autoimmune …
Averting inflammation by targeting the cytokine environment
M Kopf, MF Bachmann, BJ Marsland - Nature Reviews Drug Discovery, 2010 - nature.com
Cytokines are key instigators and regulators of immune responses and therefore hold great
potential as targets for new therapeutic strategies. However, the selection of which cytokines …
potential as targets for new therapeutic strategies. However, the selection of which cytokines …
[PDF][PDF] Cytokines as therapeutic targets: advances and limitations
C Scheinecker, K Redlich, JS Smolen - Immunity, 2008 - cell.com
Commentary Page 1 Immunity Commentary Cytokines as Therapeutic Targets: Advances and
Limitations Clemens Scheinecker,1 Kurt Redlich,1 and Josef S. Smolen1,* 1Division of …
Limitations Clemens Scheinecker,1 Kurt Redlich,1 and Josef S. Smolen1,* 1Division of …
Anti-inflammatory cytokines and cytokine antagonists
TJ Standiford - Current Pharmaceutical Design, 2000 - ingentaconnect.com
Cytokines are critical mediators of protective host responses, including defense against
microbial invasion and tumorigenesis. However, the production of specific proinflammatory …
microbial invasion and tumorigenesis. However, the production of specific proinflammatory …
Resolution of inflammation: the beginning programs the end
CN Serhan, J Savill - Nature immunology, 2005 - nature.com
Acute inflammation normally resolves by mechanisms that have remained somewhat
elusive. Emerging evidence now suggests that an active, coordinated program of resolution …
elusive. Emerging evidence now suggests that an active, coordinated program of resolution …
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
M Silacci, W Lembke, R Woods, I Attinger-Toller… - MAbs, 2016 - Taylor & Francis
Biologic treatment options such as tumor necrosis factor (TNF) inhibitors have revolutionized
the treatment of inflammatory diseases, including rheumatoid arthritis. Recent data suggest …
the treatment of inflammatory diseases, including rheumatoid arthritis. Recent data suggest …
Macrophages in inflammation
N Fujiwara, K Kobayashi - Current Drug Targets-Inflammation & …, 2005 - ingentaconnect.com
The inflammatory process is usually tightly regulated, involving both signals that initiate and
maintain inflammation and signals that shut the process down. An imbalance between the …
maintain inflammation and signals that shut the process down. An imbalance between the …
Clinical targeting of the TNF and TNFR superfamilies
M Croft, CA Benedict, CF Ware - Nature reviews Drug discovery, 2013 - nature.com
Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
RO Williams, E Paleolog, M Feldmann - Current opinion in pharmacology, 2007 - Elsevier
The clinical success of TNFα blocking biologics in a growing number of immune-mediated
pathologies, including rheumatoid arthritis, Crohn's disease, ankylosing spondylitis and …
pathologies, including rheumatoid arthritis, Crohn's disease, ankylosing spondylitis and …